PAVmed, Inc. (PAVM)
4.98
+0.30
(+6.41%)
USD |
NASDAQ |
Jun 10, 16:00
5.03
+0.05
(+1.00%)
Pre-Market: 20:00
PAVmed Total Assets (Quarterly) : 45.42M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 45.42M |
| December 31, 2025 | 38.81M |
| September 30, 2025 | 38.07M |
| June 30, 2025 | 43.89M |
| March 31, 2025 | 52.82M |
| December 31, 2024 | 30.66M |
| September 30, 2024 | 30.55M |
| June 30, 2024 | 39.41M |
| March 31, 2024 | 37.25M |
| December 31, 2023 | 33.12M |
| September 30, 2023 | 42.02M |
| June 30, 2023 | 53.68M |
| March 31, 2023 | 65.29M |
| December 31, 2022 | 53.98M |
| September 30, 2022 | 72.46M |
| June 30, 2022 | 82.45M |
| March 31, 2022 | 84.33M |
| December 31, 2021 | 86.98M |
| September 30, 2021 | 42.98M |
| June 30, 2021 | 47.37M |
| March 31, 2021 | 51.37M |
| December 31, 2020 | 19.78M |
| September 30, 2020 | 10.50M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.882M |
| March 31, 2020 | 10.11M |
| December 31, 2019 | 7.240M |
| September 30, 2019 | 4.406M |
| June 30, 2019 | 7.060M |
| March 31, 2019 | 4.356M |
| December 31, 2018 | 8.496M |
| September 30, 2018 | 9.398M |
| June 30, 2018 | 11.24M |
| March 31, 2018 | 3.759M |
| December 31, 2017 | 1.640M |
| September 30, 2017 | 3.233M |
| June 30, 2017 | 0.2265M |
| March 31, 2017 | 1.094M |
| December 31, 2016 | 0.8704M |
| September 30, 2016 | 1.986M |
| June 30, 2016 | 3.153M |
| March 31, 2016 | 0.7813M |
| December 31, 2015 | 1.214M |
| September 30, 2015 | 1.810M |
| June 30, 2015 | 0.5731M |
| March 31, 2015 | 0.7908M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | 34.08M |
| Alphatec Holdings, Inc. | 799.48M |
| SINTX Technologies, Inc. | 7.811M |
| PROCEPT BioRobotics Corp. | 487.06M |
| Abbott Laboratories | 110.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.43M |
| Shareholders Equity (Quarterly) | 39.52M |
| Debt to Equity Ratio | 0.4304 |
| Current Ratio | 2.024 |
| Net Debt Paydown Yield | 31.76% |